Abstract
Red yeast rice is a commonly used supplement in North America, primarily promoted for lowering cholesterol. The fermentation process for producing red yeast rice naturally produces a small concentration of lovastatin and related compounds. The authors evaluated label information and contacted manufacturers to inquire about lovastatin content in 117 commercially available red yeast rice supplement products. Only 14% of the products evaluated included information about lovastatin content on the label. More than 80% of the products had no information on the label and the manufacturer was not able or willing to provide any information about lovastatin content. Many consumers who choose to take red yeast rice choose to do so in order to avoid conventional prescription medications such as statin drugs. Most of these consumers do not realize that red yeast rice can contain the prescription drug lovastatin. Red yeast rice manufacturers often do not disclose to consumers that these products contain lovastatin.
Original language | English |
---|---|
Pages (from-to) | 104-107 |
Number of pages | 4 |
Journal | Journal of Evidence-Based Complementary and Alternative Medicine |
Volume | 17 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2012 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Complementary and alternative medicine
Cite this
Lovastatin Content of Commercially Available Red Yeast Rice Supplements. / Gregory, Philip J.; Pettit, Rebecca; Cochrane, Zara Risoldi; Wilson, Amy F.; Abe, Andrew M.
In: Journal of Evidence-Based Complementary and Alternative Medicine, Vol. 17, No. 2, 04.2012, p. 104-107.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Lovastatin Content of Commercially Available Red Yeast Rice Supplements
AU - Gregory, Philip J.
AU - Pettit, Rebecca
AU - Cochrane, Zara Risoldi
AU - Wilson, Amy F.
AU - Abe, Andrew M.
PY - 2012/4
Y1 - 2012/4
N2 - Red yeast rice is a commonly used supplement in North America, primarily promoted for lowering cholesterol. The fermentation process for producing red yeast rice naturally produces a small concentration of lovastatin and related compounds. The authors evaluated label information and contacted manufacturers to inquire about lovastatin content in 117 commercially available red yeast rice supplement products. Only 14% of the products evaluated included information about lovastatin content on the label. More than 80% of the products had no information on the label and the manufacturer was not able or willing to provide any information about lovastatin content. Many consumers who choose to take red yeast rice choose to do so in order to avoid conventional prescription medications such as statin drugs. Most of these consumers do not realize that red yeast rice can contain the prescription drug lovastatin. Red yeast rice manufacturers often do not disclose to consumers that these products contain lovastatin.
AB - Red yeast rice is a commonly used supplement in North America, primarily promoted for lowering cholesterol. The fermentation process for producing red yeast rice naturally produces a small concentration of lovastatin and related compounds. The authors evaluated label information and contacted manufacturers to inquire about lovastatin content in 117 commercially available red yeast rice supplement products. Only 14% of the products evaluated included information about lovastatin content on the label. More than 80% of the products had no information on the label and the manufacturer was not able or willing to provide any information about lovastatin content. Many consumers who choose to take red yeast rice choose to do so in order to avoid conventional prescription medications such as statin drugs. Most of these consumers do not realize that red yeast rice can contain the prescription drug lovastatin. Red yeast rice manufacturers often do not disclose to consumers that these products contain lovastatin.
UR - http://www.scopus.com/inward/record.url?scp=84858717194&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84858717194&partnerID=8YFLogxK
U2 - 10.1177/2156587211434490
DO - 10.1177/2156587211434490
M3 - Article
AN - SCOPUS:84858717194
VL - 17
SP - 104
EP - 107
JO - Journal of Evidence-Based Integrative Medicine
JF - Journal of Evidence-Based Integrative Medicine
SN - 2156-5872
IS - 2
ER -